A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer
Clinical trial NCT04308785 · TERMINATED
Trial details
- NCT number
- NCT04308785
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-07-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.